US Broker Ratings

Medpace Holdings, Inc. (MEDP) Stock Analysis: A Closer Look at Its Robust Return on Equity and Revenue Growth

Medpace Holdings, Inc. (MEDP), a key player in the healthcare sector, stands out in the diagnostics and research industry. With a market capitalization of $8.93 billion, Medpace has established a..

Bio-Techne Corp (TECH) Stock Analysis: Exploring a 29.78% Potential Upside in the Biotech Sector

Bio-Techne Corporation (NASDAQ: TECH), a key player in the biotechnology sector, has established a robust presence in the healthcare industry with a market capitalization of $8.13 billion. Headquartered in Minneapolis,..

Avantor, Inc. (AVTR) Stock Analysis: Navigating a 25% Potential Upside in the Healthcare Sector

Avantor, Inc. (NYSE: AVTR), a key player in the healthcare sector, has captured the attention of investors with its robust potential upside of 25.08%. Headquartered in Radnor, Pennsylvania, Avantor specializes..

Eli Lilly (LLY) Stock Analysis: A 22.76% Potential Upside Amid Robust Revenue Growth

Eli Lilly and Company (NYSE: LLY), a stalwart in the healthcare sector, continues to capture investor attention with its robust revenue growth and promising pipeline of pharmaceuticals. With a market..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: A Healthcare Powerhouse with 57.45% Potential Upside

Lantheus Holdings, Inc. (NASDAQ: LNTH), a leading player in the healthcare industry, is capturing investor interest with its robust product portfolio and potential for significant stock appreciation. With a market..

RadNet, Inc. (RDNT) Stock Analysis: A 25% Upside Potential Backed by Strong Buy Ratings

RadNet, Inc. (NASDAQ: RDNT) is carving a niche in the Healthcare sector, particularly within the Diagnostics & Research industry. With a market capitalization of $4.29 billion, RadNet stands as a..

Axsome Therapeutics, Inc. (AXSM) Stock Analysis: Exploring a 71% Upside Potential in Biotech Innovation

Axsome Therapeutics, Inc. (NASDAQ: AXSM) has been gaining considerable attention in the healthcare sector, particularly within the biotechnology industry. With a market cap of $5.09 billion, this New York-based biopharmaceutical..

Ascendis Pharma A/S (ASND) Stock Analysis: Unveiling a 34% Upside Potential in Biotech

Ascendis Pharma A/S (NASDAQ: ASND), a prominent player in the biotechnology sector, is capturing investor attention with its promising growth potential and innovative TransCon technology platform. With a market capitalization..

Labcorp Holdings Inc. (LH) Stock Analysis: A Deep Dive into Growth Potential with a 6.38% Upside

Labcorp Holdings Inc. (NYSE: LH) stands as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. Headquartered in Burlington, North Carolina, Labcorp’s reach extends across..

Merit Medical Systems, Inc. (MMSI): Investor Outlook Highlights 16% Upside Potential

Investors considering an entry into the medical instruments sector might find Merit Medical Systems, Inc. (NASDAQ: MMSI) an intriguing prospect. With its headquarters nestled in South Jordan, Utah, this company..

Intuitive Surgical, Inc. (ISRG) Stock Analysis: A Robust 7.83% Potential Upside as the Healthcare Innovator Advances

Intuitive Surgical, Inc. (NASDAQ: ISRG), a formidable player in the healthcare sector, operates at the cutting edge of medical technology. With a market capitalization of $191.29 billion, the company is..

Mettler-Toledo International, Inc. (MTD): Investor Outlook on Growth and Market Position

Mettler-Toledo International, Inc. (MTD), a key player in the healthcare sector specializing in diagnostics and research, commands a formidable presence in the global market with a market capitalization of $24.62..

Roivant Sciences Ltd. (ROIV): Investor Outlook Reveals 47% Upside Potential

Roivant Sciences Ltd. (NASDAQ: ROIV), a UK-based biotechnology company, is capturing investor attention with its promising pipeline and substantial market potential. As a clinical-stage biopharmaceutical company, Roivant focuses on developing..

Centene Corporation (CNC) Investor Outlook: Unpacking a Potential 41.69% Upside

Centene Corporation (NYSE: CNC), a major player in the healthcare plans industry, continues to capture investor attention with its growth potential and diverse service offerings. As the healthcare landscape evolves,..

Genmab A/S (GMAB) Stock Analysis: A Danish Biotech Powerhouse with 44.82% Potential Upside

For investors seeking growth opportunities in the healthcare sector, Genmab A/S (GMAB) offers a compelling prospect. As a leading biotechnology firm based in Denmark, Genmab is making significant strides in..

ICON plc (ICLR) Stock Analysis: Unpacking the 21.20% Potential Upside

Investors searching for opportunities in the healthcare sector may find ICON plc (NASDAQ: ICLR) an intriguing prospect. As a prominent player in the diagnostics and research industry, ICON plc has..

Repligen Corporation (RGEN) Investor Outlook: A 46.73% Upside Potential in Bioprocessing Technologies

Repligen Corporation (NASDAQ: RGEN), a prominent player in the healthcare sector, specializes in developing cutting-edge bioprocessing technologies that cater to the life sciences industry. With a market capitalization of $6.94..

Natera, Inc. (NTRA) Stock Analysis: Navigating Growth in the Diagnostics Sector with a 14.78% Upside Potential

Natera, Inc. (NTRA), a prominent player in the healthcare sector, particularly in diagnostics and research, offers investors a compelling growth narrative. With a market capitalization of $22.93 billion, this U.S.-based..

Corcept Therapeutics (CORT) Stock Analysis: Exploring an 88% Upside Potential

Investors seeking opportunities in the biotechnology sector should turn their attention to Corcept Therapeutics Incorporated (CORT), a dynamic player in the healthcare industry. With its focus on developing medications for..

Qiagen N.V. (QGEN) Stock Analysis: Navigating a 4.94% Potential Upside

For investors eyeing the healthcare sector, Qiagen N.V. (NYSE: QGEN) presents a compelling opportunity with its solid footing in the diagnostics and research industry. Headquartered in Venlo, the Netherlands, Qiagen..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds